Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Neurophotonics Market size was valued at USD 2.2 billion in 2024 and is anticipated to surpass USD 8.1 billion by 2037, registering a CAGR of 11.5% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of neurophotonics is evaluated at USD 2.5 billion.
The neurophotonics market is witnessing tremendous growth with the AI-powered tools utilizing machine learning-based algorithms and computer vision-based algorithms. They provide the capability of detecting clinically meaningful information from highly complex neurophotonics data through machine-supported image analysis and processing of information. For instance, in December 2024, the first FDA-approved AI-powered portable magnetic resonance (MR) brain imaging system, the Swoop system, developed by Hyperfine Inc., has revolutionized brain imaging. It has expanded its commercial operations globally by entering into agreements with seasoned distributors to increase access to MR brain imaging in areas with high population densities, poor MRI penetration, and substantial unmet healthcare needs.
Moreover, the incidence of neurodegenerative diseases such as Alzheimer's and Parkinson's disease necessitates developing non-invasive and high-resolution imaging instruments for early detection of diseases and therapy monitoring. For instance, in March 2024, according to reports from the Lancet Neurology, neurological disorders currently account for 3.4 billion individuals worldwide and are the primary cause of illness and disability. In 2021, neurological disorders accounted for 443 million years of healthy life lost as a result of illness, impairment, and early death (disability-adjusted life years), surpassing cardiovascular illnesses as the leading cause of the world's disease burden.
Neurophotonics Sector: Growth Drivers and Challenges
Growth Drivers
- Development of minimally invasive techniques: Improvements in minimally invasive neurophotonics technology are an important factor for market growth. These methods, facilitated by fiber-optic and optical probes, allow high-resolution visualization and control of the neural tissues with less patient trauma. For instance, in February 2025, a novel technique for deep brain stimulation has been created by researchers from Allegheny Health Network and Carnegie Mellon University. The method, known as DeepFocus, achieves more precise electrical stimulation in the brain by using transnasal electrical stimulation (TnES) and transcranial electrical stimulation (TES) on the scalp.
- Development of optogenetics: An exceptional driver for neurophotonics market is discovery of optogenetics. It enables unparalleled exploration of neural circuits and function. Thus, the ability to control neural activity with high spatiotemporal resolution enables explanation of complex neurological processes and design of targeted therapies. For instance, in November 2024, a research study from University of California, indicates that optogenetics holds promise as a novel treatment for epilepsy. The team of researchers found that it has a potential for treating epilepsy that employs light pulses to suppress seizure-like activity in brain cells.
Challenges
- Limited tissue penetration: The necessity of developing sophisticated optical techniques to minimize scattering and enhance penetration depth pose a crucial challenge in neurophotonics market. Hence, innovation in tissue clearing methods and optical technology is urgently required to breach this veil of penetration and advance the clinical utility of neurophotonics further. Moreover, the tissue clearing methods are crucial to be discovered to overcome penetration barrier and expand the clinical utility of neurophotonics.
- Integration with existing clinical workflows: Incorporating neurophotonics technology into existing clinical practice is a radical challenge in the neurophotonics market that involves careful planning of infrastructural and procedural adjustments. Existing clinical practices, being embedded in strongly rooted imaging modalities and analytical techniques, will not be able to change according to the specific needs of neurophotonics devices. Thus, specialized clinical training in advanced data acquisition and analysis, which is an intrinsic feature of neurophotonics, will be disruptive to current workflow.
Neurophotonics Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.5% |
|
Base Year Market Size (2024) |
USD 2.2 billion |
|
Forecast Year Market Size (2037) |
USD 8.1 billion |
|
Regional Scope |
|
Neurophotonics Segmentation
Technique (Microscopy (Two-photon Microscopy, Confocal Microscopy), Spectroscopy, Fiber Optic Imaging, Multimodal Imaging)
Based on the technique, the microscopy segment is expected to capture over 34.8% neurophotonics market share by 2037, owing to the improved new methods that provide high resolution for visualization of neural structure and dynamic function. For instance, in August 2024, a novel microscope created by UC Davis researchers can take fast pictures of brain cell activity while causing less damage to brain tissue. The novel method helped researchers better understand how neurons interact in real time in mouse studies, which could lead to new understandings of neurological disorders and brain function. This implies that complementarity of ongoing application and continuous innovation in microscopy techniques sustains its dominance at the frontier of the market.
Application (Research, Diagnostics, Therapeutics)
The research segment is anticipated to dominate the neurophotonics market primarily because it fuels tech innovation and scientific discovery. For instance, in March 2021, in the journal Nature Communications, researchers from the University of Illinois Urbana-Champaign detailed the method, known as Photonic Resonator Interferometric Scattering Microscopy, or PRISM. This novel type of microscopy enhances the interaction between biological materials and light is used to perform extremely sensitive and quick diagnostic tests as well as a very effective tool for comprehending biological processes at the size of individual objects. Thus, continued growth of new scientific knowledge solidifies the research component's role as a market driver of the market.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
|
End use |
|
|
Techniques |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportNeurophotonics Industry - Regional Synopsis
North America Market Statistics
North America in neurophotonics market is estimated to capture over 56.1% revenue share by 2037. North America is home to a sizable number of research labs. Furthermore, the market is expanding as a result of more surgeries, government-funded research and development, and the region's aging population. Moreover, medical device industry in the region is renowned for creating high-quality, technologically advanced goods as a result of increasing investment and in-depth market research.
In the U.S. neurophotonics market is likely to unveil lucrative growth opportunities owing to the research and developments programs conducted by companies in collaborations with the research institutions to foster advanced mechanism for treating neurological disorders. For instance, in November 2024, the research partnership between ZEISS Research Microscopy Solutions and the Max Planck Florida Institute for Neuroscience (MPFI) has been extended for an additional two years. This expansion strengthens their dedication to advancing brain science by creating state-of-the-art microscopy methods and sophisticated analysis tools, building on a collaboration that started in 2019.
Canada neurophotonics market is exponentially increasing its footprints owing to the local government support in exploring the therapeutic areas of brain health to carve specified treatment models for patients. For instance, in September 2024, the Government of Canada and its partners, Heart & Stroke and Brain Canada announced to spend USD 10 million to create two new national research networks for women's heart and brain health. The intersectional approach being used to investigate relationship between women's heart and brain health to significantly improve women's care and save lives and render precision medicine techniques tailored to their needs.
Asia Pacific Market Analysis
The neurophotonics market in Asia Pacific is likely to witness fastest growth during the stipulated timeframe attributable to the growing focus on light-based technologies in neurology owing to their advantages over other methods. Moreover, in the biomedicinal field, the company and researchers are opting for optical technologies for the assessment and treatment of various medical diseases. Hence, it is helping to broaden the scope of neurological study and the causes and remedies for its disorders.
In India neurophotonics market is likely to witnessing robust growth owing to the ongoing revolutions made by the inquisitive researchers in expediting the therapies and novel drugs for the brain disorders. For instance, in December 2024, Detailed 3D scans of the fetal brain are released by IIT Madras. The information, known as "DHARANI," is open to all researchers and can aid in the creation of therapies for illnesses affecting the brain. The study will appear in the Journal of Comparative Neurology's special issue.
China neurophotonics market is likely to flourish at a fast pace during the stipulated timeline due to strategic collaborations between industry, academia, and companies. For instance, in Janauray 2022, XingImaging and positron emission tomography (PET) acquisition company, and Clario have extended their collaboration to provide PET imaging clinical trials for testing new treatments in China. The new expanded offering speeds up clinical research and drug and pharma development in China by utilizing the combined resources and neuroscience expertise of Clario and XingImaging.
Companies Dominating the Neurophotonics Landscape
- Bruker Corp.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Cairn Research Ltd.
- Carl Zeiss AG
- Femtonics Ltd.
- Artinis Medical Systems
- HORIBA Ltd.
- Intelligent Imaging Innovations Inc.
- ISS Inc.
- Nanoscope Technologies LLC
- NIRx Medical Technologies LLC.
- PerkinElmer Inc
- Thermo Fisher Scientific Inc.
- Vielight Inc.
The competitive landscape in the neurophotonics market is influenced by both new and exisiting market players. To increase their market presence, businesses are employing a range of tactics, including partnerships, mergers and acquisitions, strategic alliances, regional growth, and the introduction of innovations in therapeutic devices and services. For instance, in May 2024, Spryte Medical's Publication in science translational medicine reports the first human application of innovative intravascular brain imaging technology.
Here's the list of some key players:
In the News
- In November 2024, GE HealthCare received the FDA 510(k) clearance for its novel SIGNATM MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new clinical imaging and neuroscience capabilities that could help detect neurological, oncological, and psychiatric conditions.
- In February 2024, Royal Philips announced the launch of Smart Quant Neuro 3D, a significant advancement in objective decision support for diagnosis and therapy assessment of brain disorders such as dementia, multiple sclerosis (MS), and traumatic brain injury (TBI).
Author Credits: Radhika Pawar
- Report ID: 7484
- Published Date: Apr 08, 2025
- Report Format: PDF, PPT
